Literature DB >> 25236923

PD-1 is not required for natural or peripherally induced regulatory T cells: Severe autoimmunity despite normal production of regulatory T cells.

Kristofor K Ellestad1, Govindarajan Thangavelu, Catherine L Ewen, Louis Boon, Colin C Anderson.   

Abstract

The expression of the coinhibitor PD-1 on T cells is important for the establishment of immune homeostasis. We previously found that PD-1 is particularly critical for the control of self-tolerance during lymphopenia-induced proliferation of recent thymic emigrants (RTEs). Previous studies suggested that PD-1 modulates the generation of Treg cells, particularly peripherally induced Treg (pTreg) cells, and controls Th17 cells. However, these conclusions were derived indirectly from studies on the ligand PD-L1, and not PD-1 itself. Herein we directly tested whether T-cell PD-1 expression was needed for Treg cell generation and examined if a paucity of Treg cells or enhanced Th17 cells could explain the severe lymphopenia-potentiated autoimmunity caused by PD-1 KO RTEs. Employing the murine FoxP3(EGFP) reporter system to simultaneously monitor conversion of WT and PD-1 KO T cells to pTreg cells in the same animal, we found that PD-1 deficiency did not inhibit pTreg cell generation or lead to Th17-cell-mediated autoimmunity. Surprisingly, pTreg cell numbers were increased in PD-1 KO versus WT cell populations. Furthermore, we noted an increased conversion to pTreg cells by RTEs. Our data suggest that the primary role for PD-1 is to restrain T-cell activation/proliferation to self-Ags rather than promote generation of Treg cells.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Autoimmunity; Coinhibition; Costimulation; Lymphopenia; Regulatory T cells; Tolerance

Mesh:

Substances:

Year:  2014        PMID: 25236923     DOI: 10.1002/eji.201444688

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia.

Authors:  Yonghong Zhang; Zhaozhao Liu; Mei Tian; Xiaohui Hu; Liling Wang; Jinlu Ji; Aihua Liao
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

2.  Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis.

Authors:  Heidi Harjunpää; Stephen J Blake; Elizabeth Ahern; Stacey Allen; Jing Liu; Juming Yan; Viviana Lutzky; Kazuyoshi Takeda; Amy Roman Aguilera; Camille Guillerey; Deepak Mittal; Xian Yang Li; William C Dougall; Mark J Smyth; Michele W L Teng
Journal:  Oncoimmunology       Date:  2018-03-26       Impact factor: 8.110

Review 3.  Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.

Authors:  Johan Verhagen; Anja Wegner; David C Wraith
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

4.  Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic mice.

Authors:  Yuqing Liu; Xiaoqi Wang; Yongping Zhu; Mingfeng Zhang; Ubaydah Nasri; Sharne S Sun; Stephen J Forman; Arthur D Riggs; Xi Zhang; Defu Zeng
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

5.  Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma.

Authors:  Yurany Blanquiceth; Ana Lucia Rodríguez-Perea; Jorge H Tabares Guevara; Luis Alfonso Correa; María Dulfary Sánchez; José Robinson Ramírez-Pineda; Paula Andrea Velilla
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

Review 6.  PD-1 and its ligands are important immune checkpoints in cancer.

Authors:  Yinan Dong; Qian Sun; Xinwei Zhang
Journal:  Oncotarget       Date:  2017-01-10

7.  MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.

Authors:  Mingfeng Zhang; Jeremy J Racine; Qing Lin; Yuqing Liu; Shanshan Tang; Qi Qin; Tong Qi; Arthur D Riggs; Defu Zeng
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

Review 8.  Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors.

Authors:  Pan Shen; Liang Han; Xin Ba; Kai Qin; Shenghao Tu
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

9.  PD-1 Controls Tonic Signaling and Lymphopenia-Induced Proliferation of T Lymphocytes.

Authors:  Kristofor K Ellestad; Jiaxin Lin; Louis Boon; Colin C Anderson
Journal:  Front Immunol       Date:  2017-10-12       Impact factor: 7.561

10.  Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1.

Authors:  Kristofor K Ellestad; Govindarajan Thangavelu; Yohannes Haile; Jiaxin Lin; Louis Boon; Colin C Anderson
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.